Evidence map›Paper›PMID 41639131›Full record

ArticleScientific reports2026

Influence of six different RE

M M El-Shabaan, Amaal Mohamed, M I Youssif, N A El-Ghamaz, E M Ahmed

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M M El-ShabaanPhysics Department, Faculty of Science, Damietta University, New Damietta, 34517, Egypt. elshabaan@gmail.com.
Amaal MohamedPhysics Department, Faculty of Science, Damietta University, New Damietta, 34517, Egypt.
M I YoussifPhysics Department, Faculty of Science, Damietta University, New Damietta, 34517, Egypt.
N A El-GhamazPhysics Department, Faculty of Science, Damietta University, New Damietta, 34517, Egypt.
E M AhmedPhysics Department, Faculty of Science, Damietta University, New Damietta, 34517, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study deals with investigation of the influence of rare-earth (RE³⁺) ions La³⁺, Nd³⁺, Gd³⁺, Ho³⁺, Er³⁺, and Yb³⁺ on the structural, photoluminescent, electrical, and thermal properties of a simple 50%B₂O₃ − 50%Na₂O glass system. The incorporation of 1 mol% RE₂O₃ systematically enhanced optical polarizability, as indicated by the increase in molar refraction (Rm) and nonlinear susceptibility (χ⁽³⁾). The Er³⁺ doped glass is exhibiting the highest value of χ⁽³⁾ ≈ 1.76 × 10⁻¹² esu. The calculated optical basicity, oxide ion polarizability, and metallization criteria confirmed the nonmetallic nature of all compositions. RE addition markedly intensified the photoluminescence emission, particularly for Gd³⁺ (> 2000 a.u.) and Er³⁺ (~ 700 a.u.), accompanied by high correlated color temperature values (CCT > 7600 K). Thermal analyses (TGA/DSC) revealed excellent stability up to 800 °C, with Tg values increasing from 422 °C (base glass) to 450 °C depending on RE type; the Nd³⁺-doped glass showed the highest thermal stability (ΔT ≈ 120 °C), implying superior glass-forming ability. All RE-doped samples displayed paramagnetic behavior, except La³⁺-doped, which remained diamagnetic. The dc conductivity decreased with decreasing ionic radius, consistent with the correlated barrier hopping (CBH) mechanism, while thermal conductivity (0.49–1.78 W m⁻¹ K⁻¹) confirmed their insulating and thermoelectric potential. Overall, the results demonstrate that RE³⁺ ions effectively tailor multifunctional characteristics of sodium borate glasses, highlighting their promise for advanced photonic and energy-related applications.

Identifiers

PMID41639131
PMCPMC12877008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.